Determination of the Degree of Esterification in Heparin Benzylates During Synthesis of Enoxaparin, a Domestic Analog of Low-Molecular-Mass Heparin


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

The esterification stage of low-molecular-mass heparin (enoxaparin) production by hydrolytic depolymerization of unfractionated heparin was studied and consisted of treating previously synthesized benzethonium heparinate with benzyl chloride. The content of benzyl moieties in the synthesized heparin benzylates and their degree of benzylation were determined using HPLC, PMR, and 13C NMR methods. A carboxylic-acid content of 0.13 ± 0.01 mol/g in the starting heparin was calculated from these results. A new method for estimating the degree of heparin benzylation from PMR and HPLC data was proposed. The benzyl content in the heparin benzylates increased with increasing molar excess of benzyl chloride.

Sobre autores

L. Frumin

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University

Email: kristina.yureva1994@mail.ru
Rússia, 78 Prosp. Vernadskogo, Moscow, 119454

K. Yur’eva

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University

Autor responsável pela correspondência
Email: kristina.yureva1994@mail.ru
Rússia, 78 Prosp. Vernadskogo, Moscow, 119454

A. Matveev

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University

Email: kristina.yureva1994@mail.ru
Rússia, 78 Prosp. Vernadskogo, Moscow, 119454

E. Vorfolomeeva

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University; Institute of Pharmaceutical Technologies

Email: kristina.yureva1994@mail.ru
Rússia, 78 Prosp. Vernadskogo, Moscow, 119454; Skolkovo, Moscow, 121353

I. Vostrov

Institute of Pharmaceutical Technologies

Email: kristina.yureva1994@mail.ru
Rússia, Skolkovo, Moscow, 121353

G. Zatonskii

G. F. Gause Institute of New Antibiotics

Email: kristina.yureva1994@mail.ru
Rússia, 11 Bol’shaya Pirogovskaya St., Moscow, 119435

D. Prokhorov

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University

Email: kristina.yureva1994@mail.ru
Rússia, 78 Prosp. Vernadskogo, Moscow, 119454

E. Zhavoronok

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University; Institute of Pharmaceutical Technologies

Email: kristina.yureva1994@mail.ru
Rússia, 78 Prosp. Vernadskogo, Moscow, 119454; Skolkovo, Moscow, 121353

A. Panov

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University; Institute of Pharmaceutical Technologies

Email: kristina.yureva1994@mail.ru
Rússia, 78 Prosp. Vernadskogo, Moscow, 119454; Skolkovo, Moscow, 121353

L. Grebenkina

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University

Email: kristina.yureva1994@mail.ru
Rússia, 78 Prosp. Vernadskogo, Moscow, 119454

N. Pyatigorskaya

I. M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia

Email: kristina.yureva1994@mail.ru
Rússia, Moscow

G. Brkich

I. M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia

Email: kristina.yureva1994@mail.ru
Rússia, Moscow

S. Kedik

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University; Institute of Pharmaceutical Technologies

Email: kristina.yureva1994@mail.ru
Rússia, 78 Prosp. Vernadskogo, Moscow, 119454; Skolkovo, Moscow, 121353

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2019